Neurotech

About:

Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.

Website: https://www.neurotechpharmaceuticals.com/

Twitter/X: NeurotechPharma

Top Investors: SV Health Investors, Apax Partners, Versant Ventures, Atlas Venture, Omega Funds

Description:

Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases—including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.

Total Funding Amount:

$49.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lincoln, Rhode Island, United States

Founded Date:

1995-01-01

Contact Email:

contact(AT)neurotechusa.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2006-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai